Medicus Pharma raises $22M via secured promissory notes from Streeterville Capital

Medicus Pharma Ltd. entered into a Notes Purchase Agreement with Streeterville Capital to issue $22 million in secured promissory notes, consisting of a $12.86 million A-1 Note and a $10 million B Note. The financing includes collateral agreements and is structured under SEC Rule 506 and Ontario securities regulations.